Azzad Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.5M Buy
64,346
+1,219
+2% +$85.2K 0.48% 45
2025
Q1
$4.64M Buy
63,127
+895
+1% +$65.8K 0.55% 42
2024
Q4
$4.08M Buy
62,232
+1,139
+2% +$74.6K 0.79% 29
2024
Q3
$4.76M Sell
61,093
-702
-1% -$54.7K 0.53% 43
2024
Q2
$4.82M Sell
61,795
-456
-0.7% -$35.6K 0.57% 33
2024
Q1
$4.22M Buy
62,251
+1,964
+3% +$133K 0.49% 56
2023
Q4
$4.06M Buy
60,287
+546
+0.9% +$36.8K 0.51% 49
2023
Q3
$4.05M Buy
59,741
+753
+1% +$51K 0.57% 40
2023
Q2
$4.22M Sell
58,988
-10,388
-15% -$743K 0.57% 42
2023
Q1
$4.82M Buy
69,376
+729
+1% +$50.6K 0.69% 27
2022
Q4
$4.65M Sell
68,647
-22,511
-25% -$1.53M 0.74% 21
2022
Q3
$4.97M Buy
91,158
+1,712
+2% +$93.3K 0.5% 54
2022
Q2
$5.71M Buy
89,446
+25,748
+40% +$1.64M 0.57% 36
2022
Q1
$4.23M Buy
63,698
+8,047
+14% +$534K 0.61% 34
2021
Q4
$3.24M Buy
55,651
+30,384
+120% +$1.77M 0.43% 69
2021
Q3
$1.52M Buy
25,267
+1,584
+7% +$95.1K 0.22% 171
2021
Q2
$1.42M Buy
23,683
+423
+2% +$25.3K 0.21% 189
2021
Q1
$1.16M Buy
23,260
+7,238
+45% +$360K 0.19% 196
2020
Q4
$801K Buy
16,022
+464
+3% +$23.2K 0.15% 213
2020
Q3
$853K Buy
15,558
+700
+5% +$38.4K 0.18% 185
2020
Q2
$786K Sell
14,858
-101
-0.7% -$5.34K 0.18% 177
2020
Q1
$668K Sell
14,959
-14,381
-49% -$642K 0.19% 179
2019
Q4
$1.51M Buy
29,340
+79
+0.3% +$4.06K 0.18% 185
2019
Q3
$1.43M Buy
29,261
+5,475
+23% +$267K 0.18% 189
2019
Q2
$982K Sell
23,786
-26
-0.1% -$1.07K 0.27% 149
2019
Q1
$963K Buy
23,812
+238
+1% +$9.62K 0.28% 139
2018
Q4
$895K Sell
23,574
-621
-3% -$23.6K 0.3% 134
2018
Q3
$957K Buy
24,195
+302
+1% +$12K 0.26% 151
2018
Q2
$839K Buy
23,893
+513
+2% +$18K 0.24% 162
2018
Q1
$818K Buy
23,380
+2,348
+11% +$82.1K 0.25% 154
2017
Q4
$730K Buy
21,032
+1,221
+6% +$42.4K 0.23% 158
2017
Q3
$671K Buy
+19,811
New +$671K 0.22% 163